Gene: RBM41
Official Full Name: RNA binding motif protein 41provided by HGNC
Gene Summary: Predicted to enable U12 snRNA binding activity and pre-mRNA intronic binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be part of U12-type spliceosomal complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14658 | RBM41 Knockout cell line (HeLa) | Human | RBM41 | 1:3~1:6 | Negative | Online Inquiry |
KO14659 | RBM41 Knockout cell line (HCT 116) | Human | RBM41 | 1:2~1:4 | Negative | Online Inquiry |
KO14660 | RBM41 Knockout cell line (HEK293) | Human | RBM41 | 1:3~1:6 | Negative | Online Inquiry |
KO14661 | RBM41 Knockout cell line (A549) | Human | RBM41 | 1:3~1:4 | Negative | Online Inquiry |
RBM41 Gene Knockout Cell Lines are specialized cellular models engineered to disrupt the RBM41 gene, a critical component involved in RNA binding and regulation within various cellular processes. By utilizing CRISPR-Cas9 gene editing technology, these knockout cell lines effectively eliminate the expression of the RBM41 gene, allowing researchers to study its role in gene expression, splicing, cell proliferation, and differentiation.
The primary function of these cell lines is to serve as powerful tools for investigating the biological implications of RBM41 in diverse contexts, such as cancer biology, neurodevelopment, and cellular stress responses. By observing the phenotypic and molecular changes that occur following the knockout of RBM41, researchers can delineate its regulatory mechanisms and pathways, providing valuable insights into disease mechanisms.
In scientific research and clinical settings, RBM41 Gene Knockout Cell Lines are crucial for understanding gene function and establishing robust models for drug screening and therapeutic experimentation. The cell lines support high-throughput screening efforts and facilitate the identification of potential targets for intervention, which is paramount in advancing personalized medicine.
Compared to alternative approach models, such as siRNA-mediated knockdown or traditional cell line manipulations, these knockout cell lines offer a more stable, permanent alteration of gene expression, resulting in clearer phenotypic assessments and reproducibility in experiments. Their precise and efficient nature makes them ideal for rigorous scientific inquiry.
For researchers and clinicians seeking to explore the functional biology of RBM41, the RBM41 Gene Knockout Cell Lines provide unmatched reliability and versatility. Investing in this product enhances the potential for breakthrough findings and advancements in the understanding of complex biological systems. Our company prides itself on expertise in genetic engineering and offers a broad range of reliable products to support innovative research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.